医学
肝细胞癌
结直肠癌
癌症
胃肠道癌
肿瘤科
内科学
出处
期刊:JAMA
[American Medical Association]
日期:2017-06-06
卷期号:317 (21): 2157-2157
被引量:2
标识
DOI:10.1001/jama.2017.6339
摘要
Regorafinib is now approved to treat patients with hepatocellular carcinoma in addition to previously approved indications for advanced gastrointestinal stromal tumors and metastatic colorectal cancer that no longer respond to treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI